Quincy Bioscience
It shouldn’t be surprising that in the renowned university town of Madison, Wisconsin, you’d find this unique biotech company. Quincy Bioscience states its focus as this:
“The discovery, development, and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging.”
In 1962 apoaequorin was discovered in jellyfish. The scientists responsible for this enormous discovery received great acclaim. Quincy Bioscience has continued their work by developing novel uses of apoaequorin. In fact, they are set apart by their cutting-edge applications for use in products to support cognitive function.
Prevagen® is the company’s primary consumer product containing apoaequorin. This dietary supplement was developed to support brain health and improve cognitive function. Double-blind and placebo-controlled trials have supported its ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment (determined by pre-trial screening).
Quincy Bioscience continues their research and development and have created products for both people and pets. Their work also extends beyond their products to education. Awareness of ways to improve brain health is part of their commitment to the public!
The team at Quincy Bioscience is comprised of professionals from many different disciplines that work together as a family. Their Core Values represent their ongoing mission: Confidence, Teamwork, Integrity, Excellence, Culture.
All of this has led to Prevagen® being the number one selling brain health supplement (per Nielsen March 2016) in chain pharmacies throughout the USA.
